ICU Medical Quarterly Cash Flow Statement
NASDAQ: ICUIHealth CareMedical/Dental InstrumentsUSD
160.32+3.14 (+2.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ICU Medical free cash flow
In the quarter ended Jun 30, 2026, ICU Medical generated $80.2 million of operating cash flow and spent $18.5 million on capital expenditures. That left free cash flow of $61.6 million, a free-cash-flow margin of 11.2% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
ICU Medical cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 19.09M | 30.13M | -15.73M | -3.40M | 35.34M | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M | -17.15M | 7.24M |
| Net Income growth (YoY) | -45.99% | — | — | — | — | — | — | -555.69% | — | — | — | — |
| Depreciation & Amortization | 49.61M | 50.03M | 50.83M | 50.80M | 49.66M | 49.45M | 52.99M | 55.67M | 55.32M | 55.53M | 57.16M | 58.37M |
| Stock-Based Compensation | 11.87M | 14.01M | 13.88M | 15.24M | 14.46M | 12.18M | 12.52M | 11.77M | 11.00M | 11.60M | 10.69M | 10.95M |
| Change in Working Capital | -6.56M | -10.12M | -9.35M | -21.32M | -26.81M | 3.16M | -41.90M | -24.43M | 34.58M | 11.78M | 53.10M | -29.11M |
| Operating Cash Flow | 80.15M | 38.91M | 60.60M | 56.71M | 11.21M | 51.33M | 40.19M | 36.10M | 81.95M | 45.79M | 91.27M | 35.16M |
| Capital Expenditures | -18.51M | -11.30M | -24.65M | -29.08M | -19.70M | -14.62M | -24.08M | -19.91M | -19.47M | -15.91M | -29.94M | -21.47M |
| Investing Cash Flow | -20.14M | -11.21M | -18.39M | -30.03M | 187.46M | -16.81M | -26.55M | -22.86M | -21.69M | -17.86M | -30.65M | -24.51M |
| Debt Repaid | -50.00M | -4.69M | -30.00M | -25.00M | -200.00M | -47.75M | -12.75M | -12.75M | -12.75M | -12.75M | -7.44M | -7.44M |
| Financing Cash Flow | -50.23M | -44.12M | -34.48M | -25.69M | -195.01M | -56.34M | -8.19M | -10.38M | -10.38M | -26.84M | -7.85M | -6.40M |
| Net Change in Cash | 9.97M | -19.63M | 8.23M | -293.00K | 10.32M | -18.86M | -3.95M | 9.86M | 51.23M | -2.80M | 57.03M | 1.30M |
| Free Cash Flow | 61.64M | 27.61M | 35.95M | 27.63M | -8.48M | 36.71M | 16.11M | 16.19M | 62.49M | 29.88M | 61.33M | 13.69M |
This table shows 12 quarterly periods of ICU Medical's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ICUI's reporting calendar. What is a cash flow statement?